USD 1.52 Billion
Report ID:
SQMIG35H2240 |
Region:
Global |
Published Date: February, 2024
Pages:
219
|Tables:
117
|Figures:
77
Gene Synthesis Market size was valued at USD 1.76 Billion in 2022 and is poised to grow from USD 2.04 Billion in 2023 to USD 6.75 Billion by 2031, at a CAGR of 16.10 % during the forecast period (2024-2031).
The market's expansion is attributed to factors such as favorable government legislation pertaining to synthetic biology. Investors have become more interested in synthetic biology research in recent years. In 2020, the computer-generated biology sector will receive around USD 8.0 billion from government and commercial investment. The COVID-19 epidemic has benefited the genetic synthesis sector by opening up new avenues for expansion. Researchers are investigating undiscovered possibilities in the field of gene synthesis, which is aiding market expansion in terms of revenue generation. The investigators at the National Institute developing Standards and Technology, for example, have created synthetic SARS-CoV-2 gene segments to aid in the development of precise and trustworthy diagnostic tests for the disease.
Synthetic DNA technical breakthroughs are gaining popularity as a possible way to address concerns about the growing number of new viruses & the potential hazards of a potential global pandemic. The SARS-CoV-2 pandemic, as well as pandemics involving other emerging diseases in the near future, can be addressed fast with the aid of this promising approach for rapidly replicating and analyzing genes of interest.
Targeted therapy has piqued the interest of the biotechnology & pharmaceutical sectors, as well as researchers. It has evolved into an important illness management technique. Targeted therapy in conjunction with immunology and chemotherapy is expected to develop rapidly in the future years. This would create profitable opportunities for existing and fledgling gene synthesis firms.
One of the major issues impeding market expansion is a lack of skilled specialists in the field of gene synthesis and biotechnology, as organizations operating in this industry would require trained and experienced personnel at their facilities. As a result, businesses are forming strategic alliances with universities to provide personnel with online workshops, in-person instruction, and sponsored projects in order to create the proper individuals. This would contribute to the expansion of the gene synthesis market.
Global Market Size
USD 1.52 Billion
Largest Segment
Antibody DNA Synthesis
Fastest Growth
Antibody DNA Synthesis
Growth Rate
16.1% CAGR
To get more reports on the above market click here to Buy The Report
The global gene synthesis market is segmented based on method, services, application, end-use, and region. Based on method the market is segmented into Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis. In terms of services, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis, Others. With respect to categorization by application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, and Disease Diagnosis. Based on End-use the market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations. Regionwise, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Analysis by Method
The solid-phase synthesis dominated the gene synthesizing market in 2022 with an estimated 35.87% of revenue. It can be used to build modified and canonical polymers of amino acids, particularly RNA or DNA, as this is a popular technology for a variety of applications and research reasons.
The majority of companies currently providing commercial gene synthesis services use a solid-phase synthesis process, utilizing several synthesizing platforms made available by businesses such as Agilent technological advances, Blue Heron Biotech, & Sloning Biotechnology, amongst others.
The PCR-based enzymes segment is predicted to grow at the fastest rate during the projection period. Certain aspects, such as its accuracy, ease of use, and fairly priced technology, are expected to enhance category expansion by 2030. It is an efficient approach for producing the A+T-rich malaria gene.
Furthermore, PCR-based gene production provides a straightforward solution to the problem of producing large amounts of tagged protein for NMR analysis when the gene encoding the protein is difficult or impossible to express efficiently. As a result, the previously mentioned uses of this technology contribute to segment growth.
Analysis by Services
The antibody-based DNA synthesis segment accounted for 60.90% of the market. The existence of various industry competitors providing antibody DNA synthesis services has contributed to the creation of gene market dominance in 2022. industries offer cloning and creation of antibody chain motifs into any vector to research institutions & biotech/pharma industries.
Twist Bioscience Company announced the debut of a high-throughput antibody manufacturing platform in April 2022. Using the antibody production procedure, customers can turn digital DNA (dDNA) sequences into pure IgG antibodies. Codex DNA, Inc. exhibited automated synthetic biology technology to accelerate discovery processes at an antibody engineering and therapeutics conference in Europe in June 2022.
To get detailed analysis on other segments, Request For Free Sample Report
North America held the highest revenue in 2022. This can be attributed to the presence of many important market participants offering gene synthesis services, as well as the increased interest of large biotechnology and pharmaceutical businesses in gene and cell technologies therapy development, the region's expanding field of synthetic biology, and growing interest in gene production in the molecular biology arena.
Asia Pacific is expected to grow at the quickest rate over the forecast period, owing to increased research activities for the creation of effective treatments, as well as increased interest in the field of synthetic biology research. Furthermore, disease incidence is increasing as a result of lifestyle changes. Improving healthcare infrastructure, the arrival of significant biotechnology organizations, and increased R&D efforts are all likely to contribute to market expansion.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Growing Applications in Research and Development
Restraints
Ethical and Regulatory Concerns
Request Free Customization of this report to help us to meet your business objectives.
Key market participants are pursuing a number of strategic initiatives, including collaborations, partnerships, & geographical expansions in favorable regions. Companies are launching new items to diversify their product portfolios in the market. ProteoGenix, for example, introduced the XtenCHO Transient CHO Expression System in March 2022.
This product makes recombinant protein manufacturing easier, which speeds up early-stage drug screening. Similarly, Integrated DNA Technology, Inc. announced the release of Alt-R HDR Donor Blocks in February 2022, allowing researchers to change the Homology-directed Repair (HDR) genome in order to produce cures.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our gene synthesis market analysis, favorable government legislation pertaining to synthetic biology is the key growth driver. Investors have become more interested in synthetic biology research in recent years. In 2020, the computer-generated biology sector will receive around USD 8.0 billion from government and commercial investment. The COVID-19 epidemic has benefited the genetic synthesis sector by opening up new avenues for expansion. Researchers are investigating undiscovered possibilities in the field of gene synthesis, which is aiding market expansion in terms of revenue generation. The investigators at the National Institute developing Standards and Technology, for example, have created synthetic SARS-CoV-2 gene segments to aid in the development of precise and trustworthy diagnostic tests for the disease.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 1.76 Billion |
Market size value in 2031 | USD 6.75 Billion |
Growth Rate | 16.10% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Gene Synthesis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Gene Synthesis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Gene Synthesis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Gene Synthesis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2240